Clinical Trials Directory

Trials / Conditions / Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1

Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1

9 registered clinical trials studyying Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1.

StatusTrialSponsorPhase
CompletedCytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia
NCT01870596
National Cancer Institute (NCI)Phase 2
CompletedTipifarnib in Treating Older Patients With Acute Myeloid Leukemia
NCT01361464
National Cancer Institute (NCI)Phase 2
TerminatedAzacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute My
NCT01260714
National Cancer Institute (NCI)Phase 1
CompletedLenalidomide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia
NCT01132586
National Cancer Institute (NCI)Phase 1
CompletedTipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast Ph
NCT00383474
National Cancer Institute (NCI)Phase 1
CompletedAzacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonoc
NCT00313586
National Cancer Institute (NCI)Phase 2
CompletedBelinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases
NCT00351975
National Cancer Institute (NCI)Phase 1
CompletedSorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blast
NCT00217646
National Cancer Institute (NCI)Phase 1
CompletedTacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease i
NCT00105001
Fred Hutchinson Cancer CenterPhase 2